Structure–activity relationships of the glucuronidation of flavonoids by human glucuronosyltransferases

Bibliography

• Williams CA, Grayer RJ. Anthocyanins and other flavonoids. Nat Prod Rep 2004;21:539-73
   PubMed Web of Science ®Google Scholar
• Erdman JW Jr, Balentine D, Arab L, Flavonoids and heart health: proceedings of the ILSI North America flavonoids workshop, May 31–June 1, 2005, Washington, DC. J Nutr 2007;137:718S-37S
   PubMed Web of Science ®Google Scholar
• Nijveldt RJ, van Nood E, van Hoorn DE, Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001;74:418-25
   PubMed Web of Science ®Google Scholar
• Grassi D, Desideri G, Croce G, Flavonoids, vascular function and cardiovascular protection. Curr Pharm Des 2009;15:1072-84
   PubMed Web of Science ®Google Scholar
• Dajas F, Arredondo F, Echeverry C, Flavonoids and the brain: evidences and putative mechanisms for a protective capacity. Curr Neuropharmacol 2005;3:193-205
   Google Scholar
• Gonzalez-Gallego J, Sanchez-Campos S, Tunon MJ. Anti-inflammatory properties of dietary flavonoids. Nutr Hosp 2007;22:287-93
   PubMed Web of Science ®Google Scholar
• Li Y, Fang H, Xu W. Recent advance in the research of flavonoids as anticancer agents. Mini Rev Med Chem 2007;7:663-78
   PubMed Web of Science ®Google Scholar
• Friedman M. Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Mol Nutr Food Res 2007;51:116-34
   PubMed Web of Science ®Google Scholar
• Marais JPJ, Deavours B, Dixon RA, Ferreira D. The stereochemistry of flavonoids. In: Grotewold E, editor. The sciences of flavonoids. New York: Springer; 2006 . p. 1-4
   Google Scholar
• Erlund I. Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology. Nutr Res 2004;24:851-74
   Web of Science ®Google Scholar
• Donnelly DMX, Boland G. Neoflavonoids. In: Harborne JB, editor, The flavonoids: advances in research since 1986. London: Chapman & Hall; 1994 . p. 239-58
   Google Scholar
• Beecher GR. Overview of dietary flavonoids: nomenclature, occurrence, and intake. J Nutr 2003;133:3248S-54S
   PubMed Web of Science ®Google Scholar
• Tomas-Barberan FA, Clifford MN. Flavanones, chalcones and dihydrochalcones - nature, occurrence and dietary burden. J Sci Food Agric 2000;80:1073-80
   Web of Science ®Google Scholar
• Sharma PR. Silymarin, a natural powerful antioxidant mixture. Recent Prog Med Plants 2006;12:151-77
   Google Scholar
• Manach C, Williamson G, Morand C, Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005;81:230S-42S
   PubMed Web of Science ®Google Scholar
• Manach C, Donovan JL. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res 2004;38:771-85
   PubMed Web of Science ®Google Scholar
• Zhang L, Zuo Z, Lin G. Intestinal and hepatic glucuronidation of flavonoids. Mol Pharm 2007;4:833-45
   PubMed Web of Science ®Google Scholar
• Otake Y, Hsieh F, Walle T. Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes. Drug Metab Dispos 2002;30:576-81
   PubMed Web of Science ®Google Scholar
• Mackenzie PI, Bock KW, Burchell B, Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 2005;15:677-85
   PubMed Web of Science ®Google Scholar
• Nakamura A, Nakajima M, Yamanaka H, Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 2008;36:1461-4
   PubMed Web of Science ®Google Scholar
• Radominska-Pandya A, Czernik PJ, Little JM, Structural and functional studies of UDP-Glucuronosyltransferases. Drug Metab Rev 1999;31:817-99
   PubMed Web of Science ®Google Scholar
• Amic D, Davidovic-Amic D, Beslo D, SAR and QSAR of the antioxidant activity of flavonoids. Curr Med Chem 2007;14:827-45
   PubMed Web of Science ®Google Scholar
• Om A, Kim JH. A quantitative structure-activity relationship model for radical scavenging activity of flavonoids. J Med Food 2008;11:29-37
   PubMed Web of Science ®Google Scholar
• Theoharides TC, Alexandrakis M, Kempuraj D, Lytinas M. Anti-inflammatory actions of flavonoids and structural requirements for new design. Int J Immunopathol Pharmacol 2001;14:119-27
   PubMed Web of Science ®Google Scholar
• Lopez-Lazaro M, Galvez M, Martin-Cordero C, Ayuso MJ. Cytotoxicity of flavonoids on cancer cell lines. Structure-activity relationship. Stud Nat Prod Chem 2002;27:891-932
   Google Scholar
• Voskresensky ON, Levitsky AP. QSAR aspects of flavonoids as a plentiful source of new drugs. Curr Med Chem 2002;9:1367-83
   PubMed Web of Science ®Google Scholar
• Vaya J, Tamir S. The relation between the chemical structure of flavonoids and their estrogen-like activities. Curr Med Chem 2004;11:1333-43
   PubMed Web of Science ®Google Scholar
• Stevenson DE, Cooney JM, Jensen DJ, Comparison of enzymically glucuronidated flavonoids with flavonoid aglycones in an in vitro cellular model of oxidative stress protection. In Vitro Cell Dev Biol Anim 2008;44:73-80
   PubMed Web of Science ®Google Scholar
• Shen Y, Chiou W, Chou Y, Chen C. Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes. Eur J Pharmacol 2003;465:171-81
   PubMed Web of Science ®Google Scholar
• Suri S, Taylor MA, Verity A, A comparative study of the effects of quercetin and its glucuronide and sulfate metabolites on human neutrophil function in vitro. Biochem Pharmacol 2008;76:645-53
   PubMed Web of Science ®Google Scholar
• Kgomotso T, Chiu F, Ng K. Genistein- and daidzein 7-O-beta -D-glucuronic acid retain the ability to inhibit copper-mediated lipid oxidation of low density lipoprotein. Mol Nutr Food Res 2008;52:1457-66
   PubMed Web of Science ®Google Scholar
• Lu H, Meng X, Li C, Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Drug Metab Dispos 2003;31:452-61
   PubMed Web of Science ®Google Scholar
• Williamson G, Barron D, Shimoi K, Terao J. In vitro biological properties of flavonoid conjugates found in vivo. Free Radic Res 2005;39:457-69
   PubMed Web of Science ®Google Scholar
• Slimestad R, Fossen T, Vågen IM. Onions: a source of unique dietary flavonoids. J Agric Food Chem 2007;55:10067-80
   PubMed Web of Science ®Google Scholar
• Mullen W, Edwards CA, Crozier A. Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br J Nutr 2006;96:107-16
   PubMed Web of Science ®Google Scholar
• Day AJ, Mellon F, Barron D, Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res 2001;35:941-52
   PubMed Web of Science ®Google Scholar
• Janisch KM, Williamson G, Needs P, Plumb GW. Properties of quercetin conjugates: modulation of LDL oxidation and binding to human serum albumin. Free Radic Res 2004;38:877-84
   PubMed Web of Science ®Google Scholar
• Ishizawa K, Izawa-Ishizawa Y, Ohnishi S, Quercetin glucuronide inhibits cell migration and proliferation by platelet-derived growth factor in vascular smooth muscle cells. J Pharmacol Sci 2009;109:257-64
   PubMed Web of Science ®Google Scholar
• van Zanden JJ, van der Woude H, Vaessen J, The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential. Biochem Pharmacol 2007;74:345-51
   PubMed Web of Science ®Google Scholar
• Steffen Y, Gruber C, Schewe T, Sies H. Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys 2008;469:209-19
   PubMed Web of Science ®Google Scholar
• O'Leary KA, Day AJ, Needs PW, Flavonoid glucuronides are substrates for human liver beta -glucuronidase. FEBS Lett 2001;503:103-6
   PubMed Web of Science ®Google Scholar
• Shimoi K. Circulating conjugated flavonoids and the sites of their metabolic activation. Kankyo Hen'igen Kenkyu 2004;26:241-6
   Google Scholar
• Kawai Y, Nishikawa T, Shiba Y, Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem 2008;283:9424-34
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Kajiya K, Terao J, Effect of quercetin conjugates on vascular permeability and expression of adhesion molecules. Biofactors 2004;22:201-4
   PubMed Web of Science ®Google Scholar
• Day AJ, Bao Y, Morgan MRA, Williamson G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med 2000;29:1234-43
   PubMed Web of Science ®Google Scholar
• Lambert JD, Sang S, Yang CS. Biotransformation of green tea polyphenols and the biological activities of those metabolites. Mol Pharm 2007;4:819-25
   PubMed Web of Science ®Google Scholar
• Sorich MJ, Smith PA, McKinnon RA, Miners JO. Pharmacophore and quantitative structure activity relationship modelling of UDP-glucuronosyltransferase 1A1 (UGT1A1) substrates. Pharmacogenetics 2002;12:635-45
   PubMedGoogle Scholar
• Hu X, Yu Y, Cao S, Ruan Z. Advances in glycosidation modification of flavonoids. Huaxue Yanjiu Yu Yingyong 2007;19:465-73
   Google Scholar
• Needs PW, Kroon PA. Convenient syntheses of metabolically important quercetin glucuronides and sulfates. Tetrahedron 2006;62:6862-8
   Web of Science ®Google Scholar
• Al-Maharik N, Botting NP. A facile synthesis of isoflavone 7-O-glucuronides. Tetrahedron Lett 2006;47:8703-6
   Web of Science ®Google Scholar
• Needs PW, Williamson G. Syntheses of daidzein-7-yl beta -D-glucopyranosiduronic acid and daidzein-4′,7-yl di-beta -D-glucopyranosiduronic acid. Carbohydr Res 2001;330:511-5
   PubMed Web of Science ®Google Scholar
• Soidinsalo O, Waehaelae K. Synthesis of daidzein 7-O-beta -D-glucuronide-4′-O-sulfate. Steroids 2007;72:851-4
   PubMed Web of Science ®Google Scholar
• Osmani SA, Bak S, Moller BL. Substrate specificity of plant UDP-dependent glycosyltransferases predicted from crystal structures and homology modeling. Phytochemistry 2009;70:325-47
   PubMed Web of Science ®Google Scholar
• Radominska-Pandya A, Bratton S, Little JM. A historical overview of the heterologous expression of mammalian UDP-glucuronosyltransferase isoforms over the past twenty years. Curr Drug Metab 2005;6:141-60
   PubMed Web of Science ®Google Scholar
• Senafi SB, Clarke DJ, Burchell B. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J 1994;303:233-40
   PubMed Web of Science ®Google Scholar
• King CD, Green MD, Rios GR, The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1. Arch Biochem Biophys 1996;332:92-100
   PubMed Web of Science ®Google Scholar
• Zhang L, Lin G, Zuo Z. Involvement of UDP-glucuronosyltransferases in the extensive liver and intestinal first-pass metabolism of flavonoid baicalein. Pharm Res 2007;24:81-9
   PubMed Web of Science ®Google Scholar
• Chen Y, Xie S, Chen S, Zeng S. Glucuronidation of flavonoids by recombinant UGT1A3 and UGT1A9. Biochem Pharmacol 2008;76:416-25
   PubMed Web of Science ®Google Scholar
• Green MD, King CD, Mojarrabi B, Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos 1998;26:507-12
   PubMed Web of Science ®Google Scholar
• Green M, Tephly T. Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein. Drug Metab Dispos 1996;24:356-63
   PubMed Web of Science ®Google Scholar
• Walle T, Otake Y, Galijatovic A, Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line Hep G2. Drug Metab Dispos 2000;28:1077-82
   PubMed Web of Science ®Google Scholar
• George S, Kasimis BS, Cogswell J, Phase I study of flavopiridol in combination with paclitaxel and carboplatin in patients with non-small-cell lung cancer. Clin Lung Cancer 2008;9:160-5
   PubMed Web of Science ®Google Scholar
• Carvajal RD, Tse A, Shah MA, A phase II study of flavopiridol (alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer. Pancreatology 2009;9:404-9
   PubMed Web of Science ®Google Scholar
• Phelps MA, Lin TS, Johnson AJ, Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia. Blood 2009;113:2637-45
   PubMed Web of Science ®Google Scholar
• Ramirez J, Iyer L, Journault K, In vitro characterization of hepatic flavopiridol metabolism using human liver microsomes and recombinant UGT enzymes. Pharm Res 2002;19:588-4
   PubMed Web of Science ®Google Scholar
• Ebner T, Burchell B. Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metab Dispos 1993;21:50-5
   PubMed Web of Science ®Google Scholar
• Zheng S, Chen S, Li X, Zeng S. Catalytic activities of recombinant human uridine 5′-diphosphate glucuronosyltransferases 1A6 on glucuronidation of phenols and carboxylic compounds. Zhongguo Yaolixue Yu Dulixue Zazhi 2006;20:60-5
   Google Scholar
• Galijatovic A, Otake Y, Walle UK, Walle T. Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells. Xenobiotica 1999;29:1241-56
   PubMed Web of Science ®Google Scholar
• Strassburg CP, Manns MP, Tukey RH. Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem 1998;273:8719-26
   PubMed Web of Science ®Google Scholar
• Cheng Z, Radominska-Pandya A, Tephly TR. Studies on the substrate specificity of human intestinal UDP-glucuronosyltransferases 1A8 and 1A10. Drug Metab Dispos 1999;27:1165-70
   PubMed Web of Science ®Google Scholar
• Basu NK, Ciotti M, Hwang MS, Differential and special properties of the major human UGT1-encoded gastrointestinal UDP-glucuronosyltransferases enhance potential to control chemical uptake. J Biol Chem 2004;279:1429-41
   PubMed Web of Science ®Google Scholar
• Lewinsky RH, Smith PA, Mackenzie PI. Glucuronidation of bioflavonoids by human UGT1A10: structure–function relationships. Xenobiotica 2005;35:117-29
   PubMed Web of Science ®Google Scholar
• Tang L, Singh R, Liu Z, Hu M. Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones. Mol Pharm 2009: published online 22 June 2009, doi:10.1021/mp8002557
   PubMedGoogle Scholar
• Liu X, Tam VH, Hu M. Disposition of flavonoids via enteric recycling: determination of the UDP-glucuronosyltransferase isoforms responsible for the metabolism of flavonoids in intact Caco-2 TC7 cells using siRNA. Mol Pharm 2007;4:873-82
   PubMed Web of Science ®Google Scholar
• King CD, Rios GR, Green MD, Tephly TR. UDP-glucuronosyltransferases. Curr Drug Metab 2000;1:143-61
   PubMed Web of Science ®Google Scholar
• Xie S, You L, Zeng S. Studies on the flavonoid substrates of human UDP-glucuronosyl transferase (UGT) 2B7. Pharmazie 2007;62:625-9
   PubMed Web of Science ®Google Scholar
• Green MD, Oturu EM, Tephly TR. Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab Dispos 1994;22:799-805
   PubMed Web of Science ®Google Scholar
• Turgeon D, Carrier J, Chouinard S, Belanger A. Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics. Drug Metab Dispos 2003;31:670-6
   PubMed Web of Science ®Google Scholar
• Jedlitschky G, Cassidy AJ, Sales M, Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. Biochem J 1999;340:837-43
   PubMed Web of Science ®Google Scholar
• Youdim KA, Shukitt-Hale B, Joseph JA. Flavonoids and the brain: interactions at the blood–brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 2004;37:1683-93
   PubMed Web of Science ®Google Scholar
• King CD, Rios GR, Assouline JA, Tephly TR. Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate. Arch Biochem Biophys 1999;365:156-62
   PubMed Web of Science ®Google Scholar
• Ohno S, Nakajin S. Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metab Dispos 2009;37:32-40
   PubMed Web of Science ®Google Scholar
• Kaivosaari S, Toivonen P, Hesse LM, Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10. Mol Pharmacol 2007;72:761-8
   PubMed Web of Science ®Google Scholar
• Itaaho K, Mackenzie PI, Ikushiro S, The configuration of the 17-hydroxy group variably influences the glucuronidation of {beta}-estradiol and epiestradiol by human UDP-glucuronosyltransferases. Drug Metab Dispos 2008;36:2307-15
   PubMed Web of Science ®Google Scholar
• Sten T, Bichlmaier I, Kuuranne T, UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly. Drug Metab Dispos 2009;37:417-23
   PubMed Web of Science ®Google Scholar
• Court MH, Hazarika S, Krishnaswamy S, Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction. Mol Pharmacol 2008;74:744-54
   PubMed Web of Science ®Google Scholar
• Finel M, Li X, Gardner-Stephen D, Human UDP-glucuronosyltransferase 1A5: identification, expression, and activity. J Pharmacol Exp Ther 2005;315:1143-9
   PubMed Web of Science ®Google Scholar
• Jin CJ, Miners JO, Lillywhite KJ, Mackenzie PI. cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily. Biochem Biophys Res Commun 1993;194:496-503
   PubMed Web of Science ®Google Scholar
• Beaulieu M, Levesque E, Hum DW, Belanger A. Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11. Biochem Biophys Res Commun 1998;248:44-50
   PubMed Web of Science ®Google Scholar
• Levesque E, Turgeon D, Carrier J, Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronosyltransferase. Biochemistry 2001;40:3869-81
   PubMed Web of Science ®Google Scholar
• Boersma MG, van der Woude H, Bogaards J, Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem Res Toxicol 2002;15:662-70
   PubMed Web of Science ®Google Scholar
• Chen YK, Chen SQ, Li X, Zeng S. Quantitative regioselectivity of glucuronidation of quercetin by recombinant UDP-glucuronosyltransferases 1A9 and 1A3 using enzymatic kinetic parameters. Xenobiotica 2005;35:943-54
   PubMed Web of Science ®Google Scholar
• Davis BD, Brodbelt JS. Regioselectivity of human UDP-glucuronosyl-transferase 1A1 in the synthesis of flavonoid glucuronides determined by metal complexation and tandem mass spectrometry. J Am Soc Mass Spectrom 2008;19:246-56
   PubMed Web of Science ®Google Scholar
• Chen J, Lin H, Hu M. Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model. Cancer Chemother Pharmacol 2005;55:159-69
   PubMed Web of Science ®Google Scholar
• Hosoda K, Furuta T, Yokokawa A, Plasma profiling of intact isoflavone metabolites by high-performance liquid chromatography and mass spectrometric identification of flavone glycosides daidzin and genistin in human plasma after administration of kinako. Drug Metab Dispos 2008;36:1485-95
   PubMed Web of Science ®Google Scholar
• Joseph TB, Wang SWJ, Liu X, Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms. MolPharm 2007;4:883-94
   PubMed Web of Science ®Google Scholar
• Doerge DR, Chang HC, Churchwell MI, Holder CL. Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab Dispos 2000;28:298-307
   PubMed Web of Science ®Google Scholar
• Pritchett LE, Atherton KM, Mutch E, Ford D. Glucuronidation of the soyabean isoflavones genistein and daidzein by human liver is related to levels of UGT1A1 and UGT1A9 activity and alters isoflavone response in the MCF-7 human breast cancer cell line. J Nutr Biochem 2008;19:739-45
   PubMed Web of Science ®Google Scholar
• Yin H, Bennett G, Jones JP. Mechanistic studies of uridine diphosphate glucuronosyltransferase. Chem Biol Interact 1994;90:47-58
   PubMed Web of Science ®Google Scholar
• Sorich MJ, McKinnon RA, Miners JO, Smith PA. The importance of local chemical structure for chemical metabolism by human uridine 5′-diphosphate-glucuronosyltransferase. J Chem Inf Model 2006;46:2692-7
   PubMed Web of Science ®Google Scholar
• Hagenauer B, Salamon A, Thalhammer T, In vitro glucuronidation of the cyclin-dependent kinase inhibitor flavopiridol by rat and human liver microsomes: involvement of UDP-glucuronosyltransferases 1A1 and 1A9. Drug Metab Dispos 2001;29:407-14
   PubMed Web of Science ®Google Scholar
• Zhang L, Lin G, Zuo Z. Position preference on glucuronidation of mono-hydroxylflavones in human intestine. Life Sci 2006;78:2772-80
   PubMed Web of Science ®Google Scholar
• Wong YC, Zhang L, Lin G, Zuo Z. Intestinal first-pass glucuronidation activities of selected dihydroxyflavones. Int J Pharm 2009;366:14-20
   PubMed Web of Science ®Google Scholar
• Stobiecki M, Kachlicki P. Isolation and identification of flavonoids. In: Grotewold E, editor, The sciences of flavonoids. New York: Springer; 2006 . p. 47-8
   Google Scholar
• Chen X, Cui L, Duan X, Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration. Drug Metab Dispos 2006;34:1345-52
   PubMed Web of Science ®Google Scholar
• Prior RL, Wu X. Anthocyanins: structural characteristics that result in unique metabolic patterns and biological activities. Free Radic Res 2006;40:1014-28
   PubMed Web of Science ®Google Scholar
• Richling E, Kraus M, Kahle K, Factors affecting the metabolic fate of bilberry anthocyanins. Abstracts of Papers, 236th ACS National Meeting, Philadelphia, PA, United States, August 17-21, 2008; AGFD-116
   Google Scholar
• Walle T, Otake Y, Brubaker JA, Disposition and metabolism of the flavonoid chrysin in normal volunteers. Br J Clin Pharmacol 2001;51:143-6
   PubMed Web of Science ®Google Scholar
• Wen X, Walle T. Methylation protects dietary flavonoids from rapid hepatic metabolism. Xenobiotica 2006;36:387-97
   PubMed Web of Science ®Google Scholar
• Wang SWJ, Chen J, Jia X, Disposition of flavonoids via enteric recycling: structural effects and lack of correlations between in vitro and in situ metabolic properties. Drug Metab Dispos 2006;34:1837-48
   PubMed Web of Science ®Google Scholar
• Natsume M, Osakabe N, Oyama M, Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: differences between human and rat. Free Radic Biol Med 2003;34:840-9
   PubMed Web of Science ®Google Scholar
• Lee HS, Ji HY, Park EJ, Kim SY. In vitro metabolism of eupatilin by multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes. Xenobiotica 2007;37:803-17
   PubMed Web of Science ®Google Scholar
• Chohan KK, Paine SW, Waters NJ. Quantitative structure activity relationships in drug metabolism. Curr Top Med Chem 2006;6:1569-78
   PubMed Web of Science ®Google Scholar
• Xie S, Chen Y, Zhang W, QSMR studies on glucuronidation of flavonoids catalyzed by human UGT1A3. Zhongguo Yaoxue Zazhi 2007;42:1505-8
   Google Scholar
• Smith PA, Sorich MJ, Low LSC, Towards integrated ADME prediction: past, present and future directions for modelling metabolism by UDP-glucuronosyltransferases. J Mol Graph Model 2004;22:507-17
   PubMed Web of Science ®Google Scholar
• Ethell BT, Ekins S, Wang J, Burchell B. Quantitative structure activity relationships for the glucuronidation of simple phenols by expressed human UGT1A6 and UGT1A9. Drug Metab Dispos 2002;30:734-8
   PubMed Web of Science ®Google Scholar
• Cermak R. Effect of dietary flavonoids on pathways involved in drug metabolism. Expert Opin Drug Metab Toxicol 2008;4:17-35
   PubMed Web of Science ®Google Scholar
• Sorich MJ, Smith PA, Miners JO, Recent advances in the in silico modelling of UDP glucuronosyltransferase substrates. Curr Drug Metab 2008;9:60-9
   PubMed Web of Science ®Google Scholar
• Miners JO, Smith PA, Sorich MJ, Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches. Annu Rev Pharmacol Toxicol 2004;44:1-25
   PubMed Web of Science ®Google Scholar
• Vaidyanathan JB, Walle T. Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. Drug Metab Dispos 2002;30:897-903
   PubMed Web of Science ®Google Scholar
• Fisher MB, Paine MF, Strelevitz TJ, Wrighton SA. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab Rev 2001;33:273-97
   PubMed Web of Science ®Google Scholar
• Barrington R, Williamson G, Bennett RN, Absorption, conjugation and efflux of the flavonoids, kaempferol and galangin, using the intestinal CaCo-2/TC7 cell model. J Funct Foods 2009;1:74-87
   PubMed Web of Science ®Google Scholar
• Yanez JA, Remsberg CM, Miranda ND, Pharmacokinetics of selected chiral flavonoids: hesperetin, naringenin and eriodictyol in rats and their content in fruit juices. Biopharm Drug Dispos 2008;29:63-82
   PubMed Web of Science ®Google Scholar
• Yáñez JA, Teng XW, Roupe KA, Davies NM. Stereospecific high-performance liquid chromatographic analysis of hesperetin in biological matrices. J Pharm Biomed Anal 2005;37:591-5
   PubMed Web of Science ®Google Scholar
• Yáñez JA, Davies NM. Stereospecific high-performance liquid chromatographic analysis of naringenin in urine. J Pharm Biomed Anal 2005;39:164-9
   PubMed Web of Science ®Google Scholar
• Vega-Villa KR, Remsberg CM, Ohgami Y, Stereospecific high-performance liquid chromatography of taxifolin, applications in pharmacokinetics, and determination in tu fu ling (Rhizoma smilacis glabrae) and apple (Malus x domestica). Biomed Chromatogr 2009;23:638-46
   PubMed Web of Science ®Google Scholar
• Yanez JA, Andrews PK, Davies NM. Methods of analysis and separation of chiral flavonoids. J Chromatogr B Analyt Technol Biomed Life Sci 2007;848:159-81
   PubMed Web of Science ®Google Scholar
• Guillemette C. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 2003;3:136-58
   PubMed Web of Science ®Google Scholar
• Nagar S, Remmel RP. Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer. Oncogene 2006;25:1659-72
   PubMed Web of Science ®Google Scholar
• Kale A, Gawande S, Kotwal S. Cancer phytotherapeutics: role for flavonoids at the cellular level. Phytother Res 2008;22:567-77
   PubMed Web of Science ®Google Scholar
• Amin A, Buratovich M. The anti-cancer charm of flavonoids: a cup-of-tea will do! Recent Pat Anticancer Drug Discov 2007;2:109-17
   PubMed Web of Science ®Google Scholar
• Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 2007;18:427-42
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen S, Li X, Genetic variants of human UGT1A3: functional characterization and frequency distribution in a Chinese Han population. Drug Metab Dispos 2006;34:1462-7
   PubMed Web of Science ®Google Scholar
• Innocenti F, Stadler WM, Iyer L, Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea. Clin Cancer Res 2000;6:3400-5
   PubMed Web of Science ®Google Scholar
• Phelps MA, Lin TS, Johnson AJ, Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia. Blood 2009;113:2637-45
   PubMed Web of Science ®Google Scholar
• Ramirez J, Liu W, Mirkov S, Lack of association between common polymorphisms in UGT1A9 and gene expression and activity. Drug Metab Dispos 2007;35:2149-53
   PubMed Web of Science ®Google Scholar
• Villeneuve L, Girard H, Fortier L, Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs. J Pharmacol Exp Ther 2003;307:117-28
   PubMed Web of Science ®Google Scholar
• Turgeon D, Carrier J, Levesque E, Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 2001;142:778-87
   PubMed Web of Science ®Google Scholar
• Strassburg CP, Strassburg A, Kneip S, Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 2002;50:259-65
   PubMed Web of Science ®Google Scholar
• Chen CY, Blumberg JB. Chapter 2: Are there age-related changes in flavonoid bioavailability? In: Meskin MS, Bidlack WR, Randolph RK, editors, Phytochemicals: aging and health. CRC Press; 2008 . p. 19-37
   Google Scholar
• Bolling BW, Court MH, Blumberg JB, Chen CY. The kinetic basis for age-associated changes in quercetin and genistein glucuronidation by rat liver microsomes. J Nutr Biochem 2009: published online 14 May 2009, doi:10.1016/j.jnutbio.2009.02.006
   PubMed Web of Science ®Google Scholar
• Liu Z, Hu M. Natural polyphenol disposition via coupled metabolic pathways. Expert Opin Drug Metab Toxicol 2007;3:389-406
   PubMed Web of Science ®Google Scholar
• Lan K, He J, Tian Y, Intra-herb pharmacokinetics interaction between quercetin and isorhamnetin. Acta Pharmacol Sin 2008;29:1376-82
   PubMed Web of Science ®Google Scholar
• Izukawa T, Nakajima M, Fujiwara R, Quantitative analysis of UGT1A and UGT2B expression levels in human livers. Drug Metab Dispos 2009: published online 13 May 2009, doi:10.1124/dmd.109.027227
   PubMed Web of Science ®Google Scholar
• Radominska-Pandya A, Ouzzine M, Fournel-Gigleux S, Magdalou J. Structure of UDP-glucuronosyltransferases in membranes. Methods Enzymol 2005;400:116-47
   PubMed Web of Science ®Google Scholar
• Gregory PA, Lewinsky RH, Gardner-Stephen DA, Mackenzie PI. Regulation of UDP glucuronosyltransferases in the gastrointestinal tract. Toxicol Appl Pharmacol 2004;199:354-63
   PubMed Web of Science ®Google Scholar
• Ng SP, Wong KY, Zhang L, Evaluation of the first-pass glucuronidation of selected flavones in gut by Caco-2 monolayer model. J Pharm Pharm Sci 2005;8:1-9
   Web of Science ®Google Scholar
• Chen J, Wang S, Jia X, Disposition of flavonoids via recycling: comparison of intestinal versus hepatic disposition. Drug Metab Dispos 2005;33:1777-84
   PubMed Web of Science ®Google Scholar
• Ruefer CE, Gerhäuser C, Frank N, In vitro phase II metabolism of xanthohumol by human UDP-glucuronosyltransferases and sulfotransferases. Mol Nutr Food Res 2005;49:851-6
   PubMed Web of Science ®Google Scholar
• Wu L, Zhang Z, Xu F, Bioequivalence study of baicalin capsules in healthy volunteers. Zhongguo Xinyao Yu Linchuang Zazhi 2005;24:687-90
   Google Scholar
• Mullen W, Archeveque M, Edwards CA, Bioavailability and metabolism of orange juice flavanones in humans: impact of a full-fat yogurt. J Agric Food Chem 2008;56:11157-64
   PubMed Web of Science ®Google Scholar
• Dupont MS, Day AJ, Bennett RN, Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans. Eur J Clin Nutr 2004;58:947-54
   PubMed Web of Science ®Google Scholar
• Brett GM, Hollands W, Needs PW, Absorption, metabolism and excretion of flavanones from single portions of orange fruit and juice and effects of anthropometric variables and contraceptive pill use on flavanone excretion. Br J Nutr 2009;101:664-75
   PubMed Web of Science ®Google Scholar